Objective-In developed countries, sclerotic and calcific degeneration of the aortic valve is a common disorder showing pathophysiologic similarities with atherothrombotic coronary disease. Light to moderate alcohol consumption has been associated with a lower risk for atherothrombotic coronary disease and mortality. Whether alcohol consumption affects the development of aortic valve sclerosis (AVS) is not well known. In the present study, we aim to analyze the crosssectional association between average daily alcohol consumption and AVS in the general population. Approach and Results-We analyzed cross-sectional data from 2022 men and women, aged 45 to 81 years, from the population-based Study of Health in Pomerania. We used a computer-assisted interview that included beverage-specific questions about quantity and frequency of alcohol over the last 30 days to calculate the average quantity of alcohol consumption (in grams of ethanol per day). AVS was ascertained by echocardiography. The prevalence of AVS was 32.3%. Average daily alcohol intake displayed a J-type relation with AVS (fully adjusted P value: 0.005). Compared with individuals with an average consumption of 10 g of alcohol per day, multivariable-adjusted odds ratios were 1.60 (95% confidence interval, 1.19-2.14) among current abstainers and 1.56 (95% confidence interval, 1.01-2.41) among individuals with an average consumption of 60 g per day. Conclusions-Our findings indicate that light to moderate alcohol consumption was associated with a lower odd of having AVS. Prospective data need to address whether alcohol consumption and related changes over time in several biological markers affect the progression of AVS. The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
I n developed countries, sclerosis and calcification of the aortic valve is a relatively common valve disorder, 1,2 affecting between 21% and 31% of adults over 65 years of age in the population. 1, [3] [4] [5] Usually, affected individuals are asymptomatic as the majority of these persons have just minor focal valve thickening or aortic valve sclerosis (AVS), without major compromise of the valve function. However, this condition also confers an increased risk for incident cardiovascular disease and mortality. 3 Indeed, a moderate proportion of individuals, ranging from 2% to 5% in population-based samples, have a more evolved disease, resulting in stenosis of the aortic valve with a consequent obstruction of the left ventricular outflow 3, 6, 7 and subsequent cardiovascular symptoms and even death if a replacement of the aortic valve is not performed. 2 The pathophysiologic mechanisms and risk factors leading to the initial sclerosis and subsequent calcification of the aortic valve are incompletely understood, but show some similarities with the atherosclerotic disease process. [8] [9] [10] Traditional risk factors, [3] [4] [5] 11, 12 as well as inflammatory markers, seem to play a role, as supported by the presence of inflammatory cells in compromised valves and high levels of circulating C-reactive protein in individuals with AVS. 13 For clinical assessment and May 2015 prevention of AVS and its complications, a good understanding of potentially modifiable risk factors (including alcohol consumption) is warranted.
Alcohol causes ≈2.7 million annual deaths and 3.9% of the global liability of disease. 14 Although heavy episodic drinking increases the risk of (and also aggravates prevalent) cardiovascular disease, 14, 15 light to moderate alcohol consumption has been repeatedly associated with a lower risk for atherothrombotic coronary disease and mortality in observational data. [16] [17] [18] [19] [20] To the best of our knowledge, the association between alcohol consumption and AVS has not been investigated. Therefore, we performed cross-sectional analyses to test this association in a large population-based sample.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. Table 1 displays important clinical characteristics of the study sample, stratified by categories of alcohol consumption. The prevalence of AVS was 32.3% (n=653) in the overall sample, with the highest prevalence of AVS in the abstainers group and the lowest in the group of individuals consuming 20 to <40 g of alcohol per day (Table 1) . Abstainers were mostly older, female, and had fewer years of education. They were also more often never smoker and had a sedentary lifestyle, but did not differ with regard to their body mass index. Although the group with >0 to <20 g of alcohol consumption per day presented with lower levels of blood pressure and prevalent hypertension than the other groups, the abstainers group had the highest prevalence of use of antihypertensive medication. Abstainers also exhibited higher levels for glycosylated hemoglobin (together with the group with ≥60 g of alcohol consumption per day), accompanied by higher prevalence of diabetes mellitus and use of antidiabetic medication, more unfavorable lipid traits, and use of lipid-lowering and of antiplatelet medication (Table 1 ).
Results

Characteristics of the Study Sample
Association Between Alcohol Consumption and AVS
In adjusted regression models, average alcohol consumption (modeled as a continuous trait) was significantly correlated with AVS. Table 2 displays odds ratios for AVS according to select percentiles of average alcohol consumption using an average consumption of 10 g/d as the reference. After adjustment for age and sex, current abstainers had odds ratios for the association with AVS of 1.73 (95% confidence interval [CI], 1.30-2.30), whereas individuals consuming on average 20 g of pure alcohol per day had 1.09 (95% CI, 0.96-1.25; overall P value <0.001; model 1, Table 2 ). Greater amounts of alcohol consumption per day were associated with greater odds ratios for AVS. This pattern persisted after additional adjustment for educational level, smoking, physical inactivity, and waist-toheight ratio (model 2, Table 2 ). In the fully adjusted model (model 2, Table 2 ), the odds ratios for AVS associated with current abstaining was 1.60 (95% CI: 1.19-2.14), whereas for the consumption of 60 g of alcohol per day, it was 1.56 (95% CI, 0.1.01-2.41; overall P value =0.005). The results of the model 2 are also presented in Figure. We also ran a model that included supplementary adjustment for systolic blood pressure and glycohemoglobin (model 3, Table 2 ) because these variables may be considered cofounders or, alternatively, intermediate pathways in the mechanisms involved in the alcohol protection against cardiovascular diseases. In general, light to moderate drinking were associated with lower odds than abstention, whereas at high-risk amounts (ie, >60/70 g of alcohol per day 21 ) were not different from abstainers (Figure) . The association between alcohol consumption and AVS did not differ significantly by sex and was not modified by age or smoking (P values for interaction >0.05).
We performed a sensitivity analysis with a statistical model adjusted for age, sex, educational level, smoking, physical inactivity, body mass index, triglycerides, high-density lipoprotein, low-density lipoprotein, and diabetes mellitus and obtained similar results (data not shown). In addition, we split the group of abstainers into 2 groups: lifetime (n=69) and 30 days abstainers, but former drinkers (n=392). We did not find a significant difference (P=0.915) in the association between alcohol consumption and AVS between these 2 groups.
Discussion
Our findings indicate a cross-sectional J-shaped association between alcohol consumption and AVS in an adult general population. Individuals with light to moderate alcohol consumption displayed the lowest odds of having AVS when compared with current abstainers and heavy drinkers. This association persisted after further adjustment for various cardiovascular and metabolic risk factors. To the best of our knowledge, this is the first study showing a correlation between light to moderate alcohol consumption and AVS.
In the Context of Published Literature
Multiple individual studies [22] [23] [24] [25] [26] [27] and meta-analyses 20,28-31 demonstrated a protective effect of light to moderate alcohol consumption on different cardiovascular traits and outcomes. Combining data from 34 prospective studies with 1 015 835 individuals, Costanzo and colleagues 30 concluded that light levels of alcohol consumption were inversely associated with all-cause mortality in both men and women. Similarly, a comprehensive review and meta-analysis based on 84 prospective cohort studies 20 reported that the consumption of alcohol in a light to moderate quantity (2.5-14.9 g/d) was inversely associated with cardiovascular events, with relative risks of 0.71 (95% CI, 0.66-0.77) for incident coronary heart disease and 0.75 (95% CI, 0.68-0.81) for coronary heart disease mortality. 20 Additional studies support a beneficial effect of light to moderate alcohol consumption also in patients with overt cardiovascular disease 27, 32 and on cardiovascular risk factors like diabetes mellitus. 14 In line with these data, we observed that light to moderate alcohol Nonstandard Abbreviations and Acronyms AVS aortic valve sclerosis consumption was associated with a lower prevalence of AVS in our general population sample, as compared with current abstainers and compared with individuals with higher alcohol consumption (>40 g/d). However, the potential cardioprotective effect of alcohol consumption is not universally accepted, and it is still a topic of controversy and debate. A recent Mendelian Randomization analysis, 33 using the genetic variant rs1229984 as a proxy for alcohol consumption, reported that individuals with a genetic predisposition for lower alcohol consumption have lower odds for cardiovascular diseases. 33 Although these data are intriguing and partially contradict observations from epidemiological studies, it has to be kept in mind that Mendelian Randomization analyses are based on important assumptions, as detailed by Hernan and Robins, 34 one of them being that the genetic variant under study affects cardiovascular diseases risk only through alcohol consumption (and not directly or through other indirect effects). 34 Thus, pleiotropy is considered one of the key limitations of Mendelian Randomization experiments. 35 In this context, it is noteworthy that the rs1229984 A-allele is associated with a broad spectrum of traditional risk factors, including blood pressure, inflammatory markers, adiposity measures, and non-high-density lipoprotein cholesterol. 33 It is well accepted that as the individuals get older, [36] [37] [38] they are likely to decrease their alcohol consumption. Furthermore, individuals with high average amount of alcohol consumption show the strongest decrease in their drinking habits or even converting to abstainers over time. 37 Thus, the group of current abstainers is heterogeneous, including lifetime abstainers and former drinkers who quit for any one of several reasons. If all these former drinkers are analyzed jointly as current abstainers, they would probably have a worse cardiovascular prognosis when compared with the individuals with light to moderate alcohol consumption. Consistent with this concept, we observed a worse cardiovascular risk profile in current abstainers as compared with individuals consuming between 0 and 20 g alcohol per day.
Notwithstanding these considerations, in our analyses, we obtained no evidence that the association between alcohol consumption and AVS was modified by age or that the strength of association with AVS differed between lifetime abstainers and 30 days abstainers, but former drinkers.
Potential Mechanisms for the Observed Association
The precise mechanisms how light to moderate alcohol consumption leads to a lower risk for cardiovascular disease and mortality are still not clear. The effects of alcohol consumption on cardiovascular risk might be mediated by changes on lipid and adipocyte hormone levels, insulin sensitivity, abdominal obesity, hemostatic factors, as well as further markers involved in the systemic inflammation and endothelial cell function, as detailed elsewhere. 15, 39 Some potentially relevant biomarkers are discussed more comprehensively in the next paragraph.
In a recent meta-analysis, 20 alcohol consumption was associated with increased levels of high-density lipoprotein cholesterol, apolipoprotein A1, and adiponectin as well lower levels of fibrinogen, making these biomarkers potential mediators for the association between alcohol and AVS. In this context, the beneficial effects of high-density lipoprotein cholesterol for the cardiovascular system are well established. 39, 40 On a parallel note, recombinant apolipoprotein A1 Milano reversed aortic valve stenosis and positively affected valve remodeling in experimental settings. [40] [41] [42] In line with these data, a recent proteomic study 43 revealed that apolipoprotein A1 and fibrinogen were significantly enriched in the valves of patients submitted to aortic valve replacement as compared with normal aortic valves. Although the presence of apolipoprotein A1 might be a protective mechanism against increased levels of low-density lipoprotein cholesterol, lipoprotein(a), and triglycerides on the aortic valve surface, the presence of fibrinogen seems Figure. Prevalence odds ratio (95% CI) for aortic valve sclerosis according to average alcohol consumption in the last 30 days (adjusted for age, sex, educational level, smoking, physical inactivity, and waist-to-height ratio). *The overall P value is a joint Wald test for the 2 polynomials representing average alcohol intake. Overall P value* <0.001 0.005 0.008
Alcohol consumption was modeled as a continuous trait using second-degree fractional polynomials in a logistic regression. The overall P value is a joint Wald test for the 2 polynomials representing average alcohol intake. CI indicates confidence interval; and OR, odds ratio. Model 1, age and sex. Model 2, Model 1+educational level, smoking, physical inactivity, and waist-to-height ratio. Model 3, Model 2+systolic blood pressure and glycohemoglobin.
*The overall P value is a joint Wald test for the 2 polynomials representing average alcohol intake.
to be implicated in the inflammatory process of the aortic valve calcification. 43 On a similar note, in patients with periodontal disease, plasma fibrinogen levels were positively associated with AVS. 44 Fibrinogen has a significant role in atherogenesis and thrombogenesis, fibrinolysis, and inflammation. 45, 46 Besides the decrease in the plasma levels of fibrinogen, it seems that alcohol also affects the stability of the fibrinogen, leading to a loosening of its structure. 45 Adiponectin, which levels also increase with the consumption of alcohol, 20 has insulin-sensitizing, anti-inflammatory, antithrombotic, and antiatherogenic effects. 47 Low levels of adiponectin were associated with increased valvular inflammation and neovascularization and faster evolution of stenosis in individuals with calcific aortic stenosis. 47
Study Limitations
Some limitations of this study should be mentioned. First, the study sample consisted of middle-aged Europeans; it is not known whether our findings are also applicable to other ethnicities and age-groups. Second, our data are cross-sectional; therefore, we cannot draw any temporal conclusions concerning cause and effect. Third, our data regarding the last 30 day of alcohol consumption only approximate long-term average alcohol consumption over the past years or decades. Chronic alcohol consumption is likely to be more relevant for the development of AVS than short-term alcohol consumption. However, the 30 day-beverage-specific quantity-frequency index (the one we used) has been validated and widely used in Germany and other European countries, 48 and alcohol consumption obtained over different reference periods have been shown to correlate reasonably well. 49 Besides that, we did not have data to differentiate sick-quitters from lifetime and other abstainers. Fourth, although we have incorporated numerous metabolic and cardiovascular risk factors in our multivariable model, we cannot exclude the possibility of further residual confounding. Besides that, for our definition of physical inactivity, we used 2 items regarding hours of exercise in summer and winter with limited validity and reliability. Finally, there are some pathophysiological pathways, for example, lifestyle, that could partially explain the observed association between alcohol consumption and AVS, but for which we had no specifically measured variable in our sample.
Regardless of these limitations, our study has also a few strengths, including the population-based setting, the large number of individuals, the use of standardized data collection methods, and the capacity to perform adjustment for a variety of clinical risk factors.
Conclusions
In conclusion, the study findings indicate that light to moderate alcohol consumption was associated with a lower risk of having AVS in men and women. Our findings require replication in independent samples, and the exact molecular mechanisms explaining this association warrant further investigations. Prospective data need to address whether alcohol consumption and changes in the above mentioned biological markers over time affect the progression of AVS.
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In developed countries, sclerotic and calcific degeneration of the aortic valve is a common disorder showing pathophysiologic similarities and joint risk factors with atherothrombotic coronary disease. Light to moderate alcohol consumption has been associated with a lower risk for atherothrombotic coronary disease and mortality. In the present study, we analyzed cross-sectional data of the population-based Study of Health in Pomerania (1035 men and 987 women; aged 45-81 years) and assessed the association between average daily alcohol consumption and aortic valve sclerosis. Average daily alcohol intake displayed a J-type relationship with aortic valve sclerosis. Thus, compared with individuals with a consumption of 10 g of alcohol per day, multivariable-adjusted odds ratios were 1.60 among current abstainers and 1.56 among individuals with a consumption of 60 g per day. Our findings indicate that light to moderate alcohol consumption was associated with a lower risk of having aortic valve sclerosis.
Significance
